Given that our analysis did not detect any correlation between the studied EPO SNPs and the presence/absence of anaemia (data not shown), it is plausible that inflammation, a key emerging risk factor for T2D, is a potential mechanism linking EPO and mortality in T2D patients. Here, EPO is linked to type 2 diabetes mellitus.